Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Organovo's peak revenue was $4.6M in 2017. The peak quarterly revenue was $1.5M in 2021(q4).
Organovo's revenue increased from $603.0k in 2011 to $109.0K currently. That's a -81.92% change in annual revenue.
| Fiscal year / year | Organovo revenue |
|---|---|
| 2011 | $603,000 |
| 2012 | $969,000 |
| 2013 | $1.2M |
| 2014 | $571,000 |
| 2015 | $1.5M |
| 2016 | $4.2M |
| 2017 | $4.6M |
| 2018 | $3.1M |
| 2019 | $2.2M |
| 2021 | $1.5M |
| 2022 | $370,000 |
| 2023 | $109,000 |
How accurately did Organovo's revenue projections match actual performance?
Organovo saw the greatest revenue growth in 2016, when revenue increased by 185.23%.
Organovo had the lowest revenue growth in 2022, when revenue changed by -75.33%.
| Year | Organovo growth |
|---|---|
| 2012 | 61%↑ |
| 2013 | 24%↑ |
| 2014 | -52%↓ |
| 2015 | 160%↑ |
| 2016 | 185%↑ |
| 2017 | 9%↑ |
| 2018 | -33%↓ |
| 2019 | -29%↓ |
| 2021 | -32%↓ |
| 2022 | -75%↓ |
| 2023 | -71%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2016 | - | - | - | $812,000 |
| 2017 | $990,000 | $1.4M | $1.2M | $1.1M |
| 2018 | $689,000 | $943,000 | $779,000 | $680,000 |
| 2019 | $668,000 | $1.2M | $298,000 | - |
| 2021 | - | - | - | $1.5M |
| 2022 | - | $77,000 | $131,000 | $162,000 |
| 2023 | $75,000 | - | $5,000 | $29,000 |
| 2024 | $39,000 | $30,000 | $24,000 | - |
Do you work at Organovo?
Did Organovo meet its revenue projections?
| CEO | Taylor Crouch |
| Industry | Commercial & Professional Services |
| Company Type | Public |
| Employees Number | 61 |
| Date Founded | 2007 |
| Headquarters | San Diego, California |
| Number of Locations | 2 |
| Revenue | $109,000 |
| Net Income | -$17,255,000 |
| Gross Proft | $1.9M (2019) |
| Tax Rate | 0.0% |
| Total Assets | $20,313,000 |
| Ticker | ONVO |
Organovo received early financing of $3.5M on 2011-11-02.
| Series | Round size | Date |
|---|---|---|
| Series A | $3.5M | 11/2011 |
| Post Ipo Equity | $15.2M | 03/2012 |
| Post Ipo Equity | $25M | 12/2012 |
| Post Ipo Equity | $46.6M | 08/2013 |
| Post Ipo Equity | $22M | 01/2021 |
| Investors | Security type |
|---|---|
| Michael Brams | Series A |
| Spencer Trask & Co. | Post Ipo Equity |
| SternAegis Ventures | Post Ipo Equity |
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cellink AB | - | - | 924 | - |
| LifeSprout | - | $1.1M | 15 | - |
| La Jolla Institute for Immunology | - | $61.6M | 200 | - |
| Tri Princeton | - | $5.0M | 49 | - |
| Buck Institute for Research on Aging | - | $10.0M | 287 | - |
| Texas Biomedical Research Institute | - | $120,000 | 5 | - |
| Parkinson's Institute and Clinical Center | - | $4.4M | 50 | - |
| J. Craig Venter Institute | - | $39.9M | 200 | - |
| Scripps Research | - | $380,000 | 1 | - |
| Public Health Resource International | - | $500,000 | 50 | - |
Zippia gives an in-depth look into the details of Organovo, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Organovo. The employee data is based on information from people who have self-reported their past or current employments at Organovo. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Organovo. The data presented on this page does not represent the view of Organovo and its employees or that of Zippia.
Organovo may also be known as or be related to ORGANOVO HOLDINGS, INC., Organovo, Organovo Holdings Inc, Organovo Holdings Inc. and Organovo Holdings, Inc.